
MSD is due to cut 148 jobs at its North Wales, Pennsylvania campus effective September 12, according to the company’s …

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

